Karijn Suijkerbuijk
UMC Utrecht Cancer Center, Netherlands
Karijn Suijkerbuijk is Professor of Immunotherapy in solid tumors and medical oncologist at the UMC Utrecht Cancer Center in the Netherlands. She underwent general medical training in Utrecht, followed by a PhD at Utrecht University and Johns Hopkins, Baltimore, USA. She completed her medical oncology training at the University Medical Center Utrecht and the Netherlands Cancer Institute (NKI) and was appointed as medical oncology consultant in Utrecht in 2016. She was appointed Associate Professor in 2019 and Full Professor at Utrecht University in 2022.
Her research interests include melanoma treatment, immunotherapeutic approaches in immunologically cold tumors and management of immune related adverse events (irAEs). She is scientific chair of the Dutch Melanoma Treatment Registry (DMTR), the largest nationwide registry of advanced melanoma worldwide and PI of several multicentre studies in the field of melanoma and immunotherapy. She has co-authored 153 scientific publications, including as lead author in JAMA Oncology, Annals of Oncology, Nature Cancer and Journal of Clinical Oncology. Within ESMO, she is melanoma faculty coordinator and was melanoma track chair for ESMO 2024.
